Search filters

List of works by Caterina Nardella

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

scientific article published on 2 June 2013

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

scientific article

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

scientific article published on 26 April 2009

Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events

scientific article published on August 2008

Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

scientific article published on 03 September 2020

Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

scientific article published on 17 August 2020

Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer

scientific article published on 22 August 2012

Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis.

scientific article

Differential requirement of mTOR in postmitotic tissues and tumorigenesis

scientific article

ETS rearrangements and prostate cancer initiation

scientific article published on February 2009

Erratum: Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

scientific article published in Nature

Faithfull modeling of PTEN loss driven diseases in the mouse

scientific article published on January 2010

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells

scientific article published on 18 July 2013

Of model pets and cancer models: an introduction to mouse models of cancer

scientific article published on 01 January 2014

Pro-senescence therapy for cancer treatment

scientific article published on 24 June 2011

Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

scientific article

Subtle variations in Pten dose determine cancer susceptibility

scientific article

The APL paradigm and the "co-clinical trial" project

scientific article published on July 2011

Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence

scientific article

Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.

scientific article

Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion

scientific article